(Q45972765)
Statements
Next-generation sequencing reveals a Novel NSCLC ALK F1174V mutation and confirms ALK G1202R mutation confers high-level resistance to alectinib (CH5424802/RO5424802) in ALK-rearranged NSCLC patients who progressed on crizotinib (English)
Sai-Hong Ignatius Ou
Michele Azada
David J Hsiang
June M Herman
Tatiana S Kain
Christina Siwak-Tapp
Cameron Casey
Jie He
Siraj M Ali